Literature DB >> 20722494

Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients.

Jaya Sanyal1, Biswanath Sarkar, Sabyasachi Ojha, Tapas Kumar Banerjee, Bidhan Chandra Ray, Vadlam Raghavendra Rao.   

Abstract

BACKGROUND: Pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2; PARK8) encoding dardarin, implicated in patients with autosomal dominant and sporadic Parkinson's disease (PD) among different ethnic groups (Ashkenazi Jews, North African Arabs, Basques) might be of some help in diagnostic screening and genetic counseling. AIM OF THE STUDY: We investigated the seven common mutations spanning exons 31, 35, and 41 reported in the LRRK2 gene among Eastern Indian patients with PD.
METHODS: Mutations R1441G, R1441C, R1441H, G2019S, Y1699C, I2020T, and I2012T were screened in 320 individuals (PD, 150 and controls, 170) by direct sequencing.
RESULTS: We did not observe any of these abovementioned mutations in our studied individuals.
CONCLUSION: We conclude that these mutations are rare causes of PD in the Eastern Indian population and, therefore, of little help for genetic counseling and diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722494     DOI: 10.1089/gtmb.2010.0054

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

1.  Evaluation of PARKIN gene variants in West Bengal Parkinson's disease patients.

Authors:  Jaya Sanyal; Arpita Jana; Epsita Ghosh; Tapas K Banerjee; Durga P Chakraborty; Vadlamudi R Rao
Journal:  J Hum Genet       Date:  2015-05-28       Impact factor: 3.172

2.  Understanding the role of genetic variability in LRRK2 in Indian population.

Authors:  Asha Kishore; Ashwin Ashok Kumar Sreelatha; Marc Sturm; Felix von-Zweydorf; Lasse Pihlstrøm; Francesco Raimondi; Rob Russell; Peter Lichtner; Moinak Banerjee; Syam Krishnan; Roopa Rajan; Divya Kalikavil Puthenveedu; Sun Ju Chung; Peter Bauer; Olaf Riess; Christian Johannes Gloeckner; Rejko Kruger; Thomas Gasser; Manu Sharma
Journal:  Mov Disord       Date:  2018-11-28       Impact factor: 10.338

Review 3.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

4.  Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism.

Authors:  Dipanwita Sadhukhan; Arindam Biswas; Arunima Bhaduri; Neelanjana Sarkar; Atanu Biswas; Shyamal K Das; Tapas K Banerjee; Kunal Ray; Jharna Ray
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

Review 5.  Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.

Authors:  Gunjan Thakur; Vikas Kumar; Keun Woo Lee; Chungkil Won
Journal:  Genes (Basel)       Date:  2022-08-11       Impact factor: 4.141

Review 6.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

7.  Patterns of linkage disequilibrium of LRRK2 across different races: implications for genetic association studies.

Authors:  Huihua Li; Yik Ying Teo; Eng King Tan
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.